CETUXIMAB VERSUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: A COMPARATIVE EFFECTIVENESS AND PATIENT-REPORTED OUTCOMES MULTICOHORT STUDY

被引：0
|
作者：
Marques, R. P. [1 ]
Heudtlass, P. [2 ]
Godinho, A. R. [2 ]
Pais, H. L. [1 ]
Quintela, A. [1 ]
Lopes, da Cruz J. P. [1 ]
Martins, A. P. [3 ]
机构：
[1] Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Ctr Hlth Evaluat & Res, Lisbon, Portugal
[3] Univ Lisbon, Fac Pharm, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN18
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] Patient-reported outcomes in metastatic castration-resistant prostate cancer
    Lesley Fallowfield
    Heather Payne
    Valerie Jenkins
    Nature Reviews Clinical Oncology, 2016, 13 : 643 - 650
  • [32] Comparative Effectiveness Study of Patient-Reported Outcomes After Proton Therapy or Intensity-Modulated Radiotherapy for Prostate Cancer
    Hoppe, Bradford S.
    Michalski, Jeff M.
    Mendenhall, Nancy P.
    Morris, Christopher G.
    Henderson, Randal H.
    Nichols, Romaine C.
    Mendenhall, William M.
    Williams, Christopher R.
    Regan, Meredith M.
    Chipman, Jonathan J.
    Crociani, Catrina M.
    Sandler, Howard M.
    Sanda, Martin G.
    Hamstra, Daniel A.
    CANCER, 2014, 120 (07) : 1076 - 1082
  • [33] Patient-Reported Outcomes After Hepatic Resection of Colorectal Cancer Metastases
    Rees, Jonathan R.
    Blazeby, Jane M.
    Fayers, Peter
    Friend, Elizabeth A.
    Welsh, Fenella K. S.
    John, Timothy G.
    Rees, Myrddin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) : 1364 - 1370
  • [34] A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer
    Helou, Joelle
    Morton, Gerard
    Kiss, Alex
    Mittmann, Nicole
    Ravi, Ananth
    Chung, Hans
    Davidson, Melanie
    Cheung, Patrick
    Bezjak, Andrea
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2022, 171 : 164 - 172
  • [35] EFFICACY OF CETUXIMAB/PANITUMUMAB AFTER PREVIOUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Gherman, Alexandra
    Cainap, Calin
    Vesa, Stefan-Cristian
    Havasi, Andrei Dan
    Trifon, Alexandra
    Cainap, Simona Sorana
    Crisan, Ovidiu
    Irimie, Alexandru
    FARMACIA, 2020, 68 (04) : 656 - 664
  • [36] Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis
    Neyns, B.
    Meert, V.
    Vandenbroucke, E.
    CURRENT ONCOLOGY, 2008, 15 (04) : 196 - 197
  • [37] Patient-reported outcomes (PROs) versus patient-reported outcome measures (PROMs)Is there a difference?
    Jokstad, Asbjorn
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2018, 4 (03): : 61 - 62
  • [38] Patient-reported outcomes in cancer survivorship
    Gordon, Brittaney-Belle E.
    Chen, Ronald C.
    ACTA ONCOLOGICA, 2017, 56 (02) : 166 - 173
  • [39] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
    Yuying Cui
    Yingxue Guo
    International Journal of Clinical Pharmacy, 2022, 44 : 843 - 851
  • [40] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
    Cui, Yuying
    Guo, Yingxue
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (04) : 843 - 851
12345